FDA Inspection 1140948 — Robert M. Wenham, M.D.

Robert M. Wenham, M.D. — FEI 3018057682

The FDA completed an inspection of Robert M. Wenham, M.D. on April 16, 2021 in Tampa, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 16, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tampa, FL (United States)

Additional Details

Clinical Investigator (CI)